Representative before the EPO

Employment test 1 - 10 employees
Company dna dehmel and bettenhausen
no operation time available
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

We have observed 53 EP applications Florian Rückerl has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11739219

METHODS FOR FRACTIONING WHEY PROTEIN ISOLATES

IPC classification:
A23J 1/20, A23J 3/08
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
The patent has been granted
EP12711484

CARDIAC REPAIR BY REPROGRAMMING OF CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES

IPC classification:
A61K 38/17, A61K 48/00, C07K 14/47, C12N 5/077
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12713737

A METHOD FOR CONTROLLING THE MAIN COMPLEX N-GLYCAN STRUCTURES AND THE ACIDIC VARIANTS AND VARIABILITY IN BIOPROCESSES PRODUCING RECOMBINANT PROTEINS

IPC classification:
C07K 14/43, C07K 14/435, C12N 5/00
Applicant:
LEK Pharmaceuticals dd
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12717317

NEW ANTIMICROBIAL AGENTS

IPC classification:
C07K 14/005
Applicant:
Lysando AG
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12814909

ADENOVIRUS E1A FRAGMENTS FOR USE IN ANTI-CANCER THERAPIES

IPC classification:
A61K 38/16, C07K 14/005
Applicant:
Saint Louis University
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
PATENT GRANTED
EP12761867

5-METHOXY. 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING

IPC classification:
C07H 19/073, C07H 19/10, C07H 19/173, C07H 19/20
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP12774049

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

IPC classification:
A61K 39/00, A61P 25/00
Applicant:
The Regents of the University of Colorado
Agent:
Martin Weber, Jones Day
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12790523

COMPOSITION FOR PROTECTION AGAINST CELL-DAMAGING EFFECTS

IPC classification:
A23L 1/03, A61K 31/122, A61K 31/198, A61K 31/225, A61K 31/375, A61K 31/455, A61K 31/522, A61P 39/06
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP12856300

METHODS AND COMPOSITIONS FOR TREATING VIRAL DISEASES

IPC classification:
A61K 31/517
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP11827555

METHODS OF TREATING CANCER COMPRISING TARGETING NQO1

IPC classification:
A61K 31/22, A61P 35/00, C12Q 1/68
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Agent:
Jarkko Kortesmaa, Zacco Sweden AB
Status:
EXAMINATION IN PROGRESS
EP13743712

INJECTION DEVICES

IPC classification:
A61M 5/31, A61M 5/46
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
PATENT GRANTED
EP13709667

SYNTHETIC LIPID BIOLOGY FOR COMBINATORIAL ENGINEERING OF ENDOTOXIN

IPC classification:
C12N 15/10, C12N 15/70
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13767943

EFFICIENT SYNTHESIS OF ETHYLENEDICYSTEINE-SUGAR CONJUGATES FOR IMAGING AND THERAPY

IPC classification:
A61K 31/425, A61K 31/70, A61K 49/06, C07D 277/04, C07D 277/06
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13772672

MULTICOLORED PH-ACTIVATABLE FLUORESCENCE NANOPLATFORM

IPC classification:
A61K 9/127
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP14193656

Oncolytic Farmington rhabdovirus

IPC classification:
A61K 35/76, A61K 35/761, A61K 35/763, A61K 35/766, A61K 35/768, A61K 45/06, A61P 35/00, A61P 35/04, C12N 7/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13791038

CELLULAR VACCINE AND METHOD OF INDUCING AN IMMUNE RESPONSE IN A SUBJECT

IPC classification:
A61K 31/711, A61K 39/00, A61K 39/21, A61K 39/29, A61P 37/04, C12N 5/0784, C12N 15/62
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13827577

ANTIMICROBIAL COMPOSITIONS COMPRISING GLYCERYL NITRATES

IPC classification:
A61K 31/045, A61K 31/21, A61P 31/00, A61P 31/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13836620

MODULATION OF PODOPLANIN MEDIATED PLATELET ACTIVATION

IPC classification:
A61K 38/00, A61P 7/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13786389

JAM-C ANTIBODIES AND METHODS FOR TREATMENT OF CANCER

IPC classification:
C07K 16/28
Applicant:
Research Development Foundation
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP11709133

IN VITRO PROCESS FOR THE QUICK DETERMINATION OF A PATIENT'S STATUS RELATING TO INFECTION WITH MYCOBACTERIUM TUBERCULOSIS

IPC classification:
G01N 33/50, G01N 33/569
Agent:
dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13814447

METHOD FOR DETERMINING COMPATIBILITY BETWEEN A DONOR AND A RECIPIENT BY MEANS OF THE FLOW CYTOMETRIC DETECTION OF ALLOREACTIVE T CELLS

IPC classification:
G01N 33/50, G01N 33/569, G01N 33/68
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13857737

HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C AND USES THEREOF

IPC classification:
A61K 39/395, C12N 15/63, C12P 21/06
Applicant:
Bayer Healthcare LLC
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Agent:
Bayer Intellectual Property GmbH
Status:
GRANT OF PATENT INTENDED
EP15151109

Anti-OX40 antibodies and methods of using the same

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/13
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP13869967

RAPAMYCIN ANALOGS TARGETING PROTEASOME FUNCTION IN THE TREATMENT OF CANCER

IPC classification:
A61P 35/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP13814441

A METHOD FOR RECOGNITION OF A PRESENCE OF AN INFECTION WITH CMV

IPC classification:
G01N 33/569
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP14742935

RECOMBINANT ANTIGENS OF PORCINE CIRCOVIRUS 2 (PCV-2) FOR VACCINE FORMULATIONS, DIAGNOSTIC KIT AND USE THEREOF

IPC classification:
A61K 39/12, A61P 31/20, C07K 14/01, C12N 15/34, G01N 33/53
Applicant:
UFV (Universidade Federal de Viçosa)
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP14760783

SPECIFIC DETECTION TOOL FOR MESENCHYMAL AND EPITHELIAL-MESENCHYMAL TRANSFORMED CIRCULATING TUMOR CELLS

IPC classification:
A61K 39/395, C07K 16/18
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14772555

HER3 SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, G01N 33/574
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14783210

TUMOR-SELECTIVE COMBINATION THERAPY

IPC classification:
A61K 31/352, A61K 45/06, C12Q 1/68
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15187399

NEW ANTIMICROBIAL AGENTS

IPC classification:
C07K 14/005
Applicant:
Lysando AG
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14800355

TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS

IPC classification:
A61K 31/485, A61K 31/5513, A61K 31/5517, A61P 25/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14766012

TENDON REPAIR SYSTEMS, DEVICES, AND KITS

IPC classification:
A61B 17/04, A61B 17/11
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP14853799

COMPOSITIONS AND METHODS OF ADMINISTERING SAME

IPC classification:
A61K 31/137, A61K 31/4168, A61K 31/485, A61K 31/5517, A61P 25/30, A61P 25/32, A61P 25/34, A61P 25/36
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
GRANT OF PATENT INTENDED
EP11779450

NUCLEAR DNA CONTENT OF CHO CELL LINES AS A SELECTION CRITERION IN SCREENING OF THE BEST RECOMBINANT PROTEIN PRODUCERS

IPC classification:
C12N 15/67, C12P 21/00, C12Q 1/68
Applicant:
LEK Pharmaceuticals dd
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11778880

NOVEL ENDOLYSIN

IPC classification:
A61K 38/46, C12N 9/36, C12N 9/52
Applicant:
Katholieke Universiteit Leuven
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14815479

BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS

IPC classification:
A61K 31/167, A61K 31/4465, A61P 35/00, C07C 235/56, C07D 207/08, C07D 211/22, C07D 211/46, C07D 401/12, C07D 451/06
Applicant:
University of Kansas
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14799418

MODIFIED KZ144 ENDOLYSIN SEQUENCE

IPC classification:
C12N 9/36, C12N 9/50
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP14799422

MODIFIED EL188 ENDOLYSIN SEQUENCE

IPC classification:
A61K 38/00, C12N 9/36, C12N 15/62
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14864015

INHIBITORS OF HSV NUCLEOTIDYL TRANSFERASES AND USES THEREFOR

IPC classification:
A01N 35/00, A61K 31/12, C07C 49/00
Applicant:
Saint Louis University
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15746353

AMINOTRIAZOLE- AND AMINOTETRAZOLE-BASED KDM1A INHIBITORS AS EPIGENETIC MODULATORS

IPC classification:
A01N 43/40, A01N 43/64, C07D 249/14, C07D 401/00
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15705587

ANTIMICROBIAL AGENTS

IPC classification:
C12N 9/36, C12N 9/80, C12N 15/62
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION IN PROGRESS
EP15743631

DRAINAGE TREATMENT SYSTEM

IPC classification:
B01D 29/00, E02B 15/04, E03F 5/14
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15715243

PHARMACEUTICAL COMPOSITION AGAINST CHRONIC BACTERIAL INFECTIONS

IPC classification:
A61K 38/46, A61P 31/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14889332

MULTIPLE SPEED PROCESS FOR PRESERVING HEAT SENSITIVE PORTIONS OF A THERMOKINETICALLY MELT BLENDED BATCH

IPC classification:
B01F 3/00, B01F 7/00, B01F 7/02, B01F 7/04
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15798855

NOVEL COMPOUNDS SUPPORTS HEMATOPOIETIC STEM CELLS AND RED BLOOD CELLS

IPC classification:
A61K 31/155, C07C 279/14
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15733579

TRIAZOLE MODIFIED COUMARIN AND BIPHENYL AMIDE-BASED HSP90 INHIBITORS

IPC classification:
A61K 31/454, A61P 35/00, C07D 401/12, C07D 405/14
Applicant:
University of Kansas
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15806650

TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE

IPC classification:
A61K 31/40, A61P 35/00, A61K 47/50
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP14894941

USB TERMINAL-EQUIPPED BATTERY

IPC classification:
H01M 2/30, H01M 10/46
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15834874

FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH

IPC classification:
A61K 31/56
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
EXAMINATION REQUESTED
EP15842037

SYRINGE INFUSION DEVICES AND SYSTEMS FOR DELIVERY OF ACTIVE AGENTS

IPC classification:
A61M 5/145
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
Request for examination was made
EP15842717

VIRAL RNA SEGMENTS AS IMMUNOMODULATORY AGENTS AND VACCINE COMPONENTS

IPC classification:
A61K 39/12, A61K 39/29, C07K 14/005, C07K 14/18, C12N 15/00, C12N 15/11
Applicant:
University of Iowa Research Foundation
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
Request for examination was made
EP15794165

PREDICTING PRODUCTIVITY IN EARLY CELL LINE DEVELOPMENT

IPC classification:
C12N 15/10, C12N 15/67
Applicant:
LEK Pharmaceuticals dd
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
Request for examination was made
EP15797902

PREDICTING GENETICALLY STABLE RECOMBINANT PROTEIN PRODUCTION IN EARLY CELL LINE DEVELOPMENT

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
LEK Pharmaceuticals dd
Agent:
Florian Rückerl, Dehmel & Bettenhausen Patentanwälte PartmbB
Status:
Request for examination was made

Please Sign in to use this feature